Given that PBLD expression is regulated by TFEB and MARCH2, we examined their expression and found that TMPD treatment upregulated Tfeb and downregulated March2 (Figure 7L), suggesting that dysregulated TFEB and MARCH2 may modulate PBLD expression in SLE. The gene discussed is TFEB; the disease is systemic lupus erythematosus.